Visit Metagene.de!
Summary
NONALCOHOLIC FATTY LIVER DISEASE DD
NAFLD
Central obesity, dyslipidaemia, hyperglycaemia, and hypertension are typical features of metabolic syndrome that seem to hesitate often in
type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, and many other clinical conditions [Mameli C 2017].
Non-alcoholic fatty liver disease (NAFLD) is considered to be the hepatic component of the metabolic syndrome and its prevalence is rapidly increasing due to its strong association with insulin resistance and obesity [Rodiriguez-Ramiro
et al. 2015]
symptoms
liver involvement or dysfunction
obesity
laboratory finding
Transaminases0.000.00 increasedserum
Literature
Eulenburg Vet al.Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexiaBiochem Biophys Res Commun3480400-4052006
Fecarotta Set al.HHH syndrome (hyperornithinaemia, hyperammonaemia, homocitrullinuria), with fulminant hepatitis-like presentationJ Inher Met Dis290186-1892006
Anselm IMet al.X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotypeJ Inher Met Dis290214-2192006
Clark AJet al.X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiologyHum Genet1190604-6102006
Poo-Arguelles Pet al.X-Linked creatine transporter deficiency in two patients with severe mental retardation and autismJ Inherit Metab Dis291220-2232006